Technical Analysis for VCYT - Veracyte, Inc.

Grade Last Price % Change Price Change
grade B 24.18 -0.86% -0.21
VCYT closed down 0.86 percent on Monday, May 20, 2019, on 75 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical VCYT trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
20 DMA Support Bullish -0.86%
50 DMA Support Bullish -0.86%
MACD Bullish Centerline Cross Bullish -3.70%
MACD Bullish Signal Line Cross Bullish -3.70%
BB Squeeze Ended Range Expansion -3.70%
Up 3 Days in a Row Strength -3.70%
Upper Bollinger Band Touch Strength -3.70%

Older signals for VCYT ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Veracyte, Inc. operates as a diagnostics company in the field of molecular cytology to enhance patient outcomes and lower healthcare costs. It provides Afirma Thyroid FNA Analysis, a solution that consists of its Gene Expression Classifier (GEC), which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. The company is also developing Afirma Malignant GEC test for rare forms of thyroid cancer or metastases to the thyroid that is intended to inform surgical strategy; and idiopathic pulmonary fibrosis and nodules suspicious products for lung cancer. It serves endocrinologists, radiologists, and head and neck specialists. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Organ Systems Gene Expression Lung Cancer Idiopathic Pulmonary Fibrosis Surgeries Glands Thyroid Thyroid Cancer
Is VCYT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 26.8
52 Week Low 6.3
Average Volume 704,420
200-Day Moving Average 16.1121
50-Day Moving Average 23.819
20-Day Moving Average 23.8145
10-Day Moving Average 23.754
Average True Range 1.4786
ADX 12.53
+DI 21.9142
-DI 25.55
Chandelier Exit (Long, 3 ATRs ) 22.3642
Chandelier Exit (Short, 3 ATRs ) 25.2143
Upper Bollinger Band 25.5545
Lower Bollinger Band 22.0745
Percent B (%b) 0.61
BandWidth 14.612946
MACD Line 0.1475
MACD Signal Line 0.099
MACD Histogram 0.0484
Fundamentals Value
Market Cap 819.54 Million
Num Shares 33.9 Million
EPS -0.80
Price-to-Earnings (P/E) Ratio -30.23
Price-to-Sales 3.94
Price-to-Book 5.91
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 24.82
Resistance 3 (R3) 24.79 24.56 24.71
Resistance 2 (R2) 24.56 24.39 24.57 24.68
Resistance 1 (R1) 24.37 24.29 24.25 24.39 24.64
Pivot Point 24.13 24.13 24.07 24.14 24.13
Support 1 (S1) 23.94 23.97 23.83 23.97 23.72
Support 2 (S2) 23.71 23.87 23.72 23.68
Support 3 (S3) 23.52 23.71 23.65
Support 4 (S4) 23.54